Drug Discovery with 65,000 Processors

Researchers at the University of Tennessee at Knoxville are developing drug discovery solutions that can run on 65,000 processors in parallel or more.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.
      Matthew Dublin is a senior writer at Genome Technology.